Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
No holdings reported for quarter Q2 2010 |
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
HH&L ACQUISITION CO | 8 | Q4 2022 | 100.0% |
SUMMIT HEALTHCRE ACQUISTN CO | 7 | Q4 2022 | 55.2% |
YS BIOPHARMA CO LTD | 6 | Q2 2024 | 1.0% |
PINDUODUO INC | 4 | Q4 2021 | 55.8% |
TAIWAN SEMICONDUCTOR MFG LTD | 4 | Q2 2024 | 63.9% |
NVIDIA CORPORATION | 4 | Q2 2024 | 35.0% |
YS BIOPHARMA CO LTD | 4 | Q4 2023 | 35.4% |
HH&L ACQUISITION CO | 4 | Q4 2023 | 0.4% |
IQIYI INC | 2 | Q2 2024 | 69.2% |
ALIBABA GROUP HLDG LTD | 2 | Q1 2023 | 54.4% |
View Valliance Asset Management Ltd's complete holdings history.
Latest filings
Type | Filed |
---|---|
N-PX | 2024-08-29 |
13F-HR | 2024-08-07 |
13F-HR | 2024-05-07 |
13F-HR | 2024-01-31 |
13F-HR | 2023-10-27 |
13F-HR | 2023-07-26 |
13F-HR | 2023-05-10 |
13F-HR | 2023-02-07 |
13F-HR | 2022-11-09 |
13F-HR | 2022-08-10 |
View Valliance Asset Management Ltd's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.